Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (61-70 of 280) with videos related to

Pageof 28
Sort By:
Molecular Carcinogenesis|March 1, 2002
Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1Sophie North, Olivier Pluquet, Daniela Maurici, et al.
Hepatitis Research and Treatment|August 27, 2011
TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S MutationsBehnoush Abedi-Ardekani, Doriane Gouas, Stephanie Villar, et al.
Cancer Letters|November 13, 2010
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-linesSuresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, et al.
Human Mutation|January 6, 2006
Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellationsEwy Mathe, Magali Olivier, Shunsuke Kato, et al.
Sarcoma|May 3, 2012
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric RhabdomyosarcomaSimona Ognjanovic, Ghyslaine Martel, Carlos Manivel, et al.
The Journal of Biological Chemistry|January 18, 2003
The cytoprotective aminothiol WR1065 activates p53 through a non-genotoxic signaling pathway involving c-Jun N-terminal kinaseOlivier Pluquet, Sophie North, Anindita Bhoumik, et al.
Critical Reviews in Clinical Laboratory Sciences|December 18, 2004
The tumor suppressor gene TP53: implications for cancer management and therapySeverine Seemann, Daniela Maurici, Magali Olivier, et al.
Cold Spring Harbor Perspectives in Medicine|June 30, 2016
The Role of the p53 Protein in Stem-Cell Biology and Epigenetic RegulationArnold J Levine, Anna M Puzio-Kuter, Chang S Chan, et al.
Cancer Genetics and Cytogenetics|September 13, 2008
Li-Fraumeni syndrome in a Malaysian kindredHany Ariffin, Ghyslaine Martel-Planche, Siti Sarah Daud, et al.
Current Opinion in Oncology|December 3, 2009
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndromeEdenir I Palmero, Maria Iw Achatz, Patricia Ashton-Prolla, et al.
Pageof 28

Showing results (61-70 of 280) with videos related to

Sort By:
Pageof 28
Molecular Carcinogenesis|March 1, 2002
Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1Sophie North, Olivier Pluquet, Daniela Maurici, et al.
Hepatitis Research and Treatment|August 27, 2011
TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S MutationsBehnoush Abedi-Ardekani, Doriane Gouas, Stephanie Villar, et al.
Cancer Letters|November 13, 2010
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-linesSuresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, et al.
Human Mutation|January 6, 2006
Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellationsEwy Mathe, Magali Olivier, Shunsuke Kato, et al.
Sarcoma|May 3, 2012
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric RhabdomyosarcomaSimona Ognjanovic, Ghyslaine Martel, Carlos Manivel, et al.
The Journal of Biological Chemistry|January 18, 2003
The cytoprotective aminothiol WR1065 activates p53 through a non-genotoxic signaling pathway involving c-Jun N-terminal kinaseOlivier Pluquet, Sophie North, Anindita Bhoumik, et al.
Critical Reviews in Clinical Laboratory Sciences|December 18, 2004
The tumor suppressor gene TP53: implications for cancer management and therapySeverine Seemann, Daniela Maurici, Magali Olivier, et al.
Cold Spring Harbor Perspectives in Medicine|June 30, 2016
The Role of the p53 Protein in Stem-Cell Biology and Epigenetic RegulationArnold J Levine, Anna M Puzio-Kuter, Chang S Chan, et al.
Cancer Genetics and Cytogenetics|September 13, 2008
Li-Fraumeni syndrome in a Malaysian kindredHany Ariffin, Ghyslaine Martel-Planche, Siti Sarah Daud, et al.
Current Opinion in Oncology|December 3, 2009
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndromeEdenir I Palmero, Maria Iw Achatz, Patricia Ashton-Prolla, et al.
Pageof 28